Injection-molded product

US12461390B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12461390-B2
Application numberUS-202017623421-A
CountryUS
Kind codeB2
Filing dateJul 1, 2020
Priority dateJul 2, 2019
Publication dateNov 4, 2025
Grant dateNov 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An injection-molded product or an eyewear is provided. The injection-molded product or the eyewear may be an optically compensated injection-molded product, which may resolve optical defects such as a rainbow phenomenon occurring in the injection-molded product or the eyewear. The injection-molded product may include an injection-molded body and a retardation film disposed on at least one side of the injection-molded body. The retardation film has an in-plane phase difference of 1,000 nm or more for light having a wavelength of 550 nm, and wherein an angle formed by a slow axis of the retardation film and an injection direction of the injection-molded body is in a range from 0 degree to 80 degrees.

First claim

Opening claim text (preview).

The invention claimed is: 1 . An injection-molded product, comprising: an injection-molded body; and a retardation film disposed on at least one side of the injection-molded body, wherein the retardation film has an in-plane phase difference of 1,000 nm or more for light having a wavelength of 550 nm and comprises only one slow axis, and wherein an angle formed by the slow axis of the retardation film and an injection direction of the injection-molded body is in a range from 0 degree to 80 degrees, wherein the injection direction is a direction along which melted plastic material is injected into a mold to form the injection-molded body, and wherein the injection-molded body has an in-plane phase difference in a range of 800 nm to 3,000 nm for light having a wavelength of 550 nm. 2 . The injection-molded product according to according to claim 1 , wherein the injection-molded body is a molded body comprising one or more plastics selected from the group consisting of polyvinyl chloride, polyolefin, polyester, nylon, polyamide, polysulfone, polyetherimide, polyethersulfone, polyphenylene sulfide, polyether ketone, polyether ether ketone, ABS resins, polystyrene, polybutadiene, polyacrylate, polyacrylonitrile, polyacetal, polycarbonate, polyphenylene ether, EVA resins, polyvinyl acetate, liquid crystal polymers, ethylene-tetrafluoroethylene copolymers, polyvinyl fluoride, polyvinylidene fluoride, polyvinylidene chloride and teflon. 3 . The injection-molded product according to claim 1 , wherein the in-plane phase difference of the retardation film is 2,000 nm or more for light having a wavelength of 550 nm. 4 . The injection-molded product according to claim 1 , wherein the in-plane phase difference of the retardation film is 3,000 nm or more for light having a wavelength of 550 nm is 3,000 nm or more. 5 . The injection-molded product according to claim 1 , wherein the retardation film is a polymer film or a liquid crystal film. 6 . The injection-molded product according to claim 1 , wherein the injection-molded body is an eyewear. 7 . An Eyewear, comprising: an eyewear body comprising a left eye region and a right eye region; and a retardation film disposed on at least one side of the eyewear body, wherein the eyewear body is an injection-molded body, wherein the retardation film has an in-plane phase difference of 1,000 nm or more for light having a wavelength of 550 nm and comprises only one slow axis, wherein an angle formed by a virtual line connecting respective mass centers of the left eye region and the right eye region in the eyewear body and a slow axis of the retardation film is from 10 degrees to 170 degrees, and wherein the eyewear body has an in-plane phase difference in a range of 800 nm to 3,000 nm for light having a wavelength of 550 nm. 8 . The eyewear according to claim 7 , wherein the eyewear body is a molded body comprising one or more plastics selected from the group consisting of polycarbonate and nylon. 9 . The eyewear according to claim 7 , wherein the in-plane phase difference of the retardation film is 2,000 nm or more for light having a wavelength of 550 nm. 10 . The eyewear according to claim 7 , wherein the in-plane phase difference of the retardation film is 3,000 nm or more for light having a wavelength of 550 nm. 11 . The eyewear according to claim 7 , wherein the retardation film is a polymer film or a liquid crystal film.

Assignees

Inventors

Classifications

  • involving passive liquid crystal elements (optical properties of liquid crystals G02F1/0063; polarising elements associated with active liquid crystal devices G02F1/133528) · CPC title

  • Lenses · CPC title

  • Polarising elements (light-modulating devices with active elements G02F1/00) · CPC title

  • Optical laminates · CPC title

  • having particular optical properties, e.g. fluorescent or phosphorescent · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12461390B2 cover?
An injection-molded product or an eyewear is provided. The injection-molded product or the eyewear may be an optically compensated injection-molded product, which may resolve optical defects such as a rainbow phenomenon occurring in the injection-molded product or the eyewear. The injection-molded product may include an injection-molded body and a retardation film disposed on at least one side …
Who is the assignee on this patent?
Lg Chemical Ltd
What technology area does this patent fall under?
Primary CPC classification B29D11/0073. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).